Walmart shares slide as U.S. sales hit by falling drug prices
The supermarket chain reported comparable U.S. sales growth of 2.6% in its second-quarter earnings, its lowest in over six years.
We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.
Other reports of this story
- Walmart shares slide as U.S. sales hit by falling drug prices marketwatch.com